BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 36233030)

  • 1. Pathogenic Roles of Heparan Sulfate and Its Use as a Biomarker in Mucopolysaccharidoses.
    Minami K; Morimoto H; Morioka H; Imakiire A; Kinoshita M; Yamamoto R; Hirato T; Sonoda H
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Enzymatic Degradation of Heparan Sulfate.
    Griffin LS; Gloster TM
    Protein Pept Lett; 2017; 24(8):710-722. PubMed ID: 28741461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses.
    Kubaski F; Suzuki Y; Orii K; Giugliani R; Church HJ; Mason RW; Dũng VC; Ngoc CT; Yamaguchi S; Kobayashi H; Girisha KM; Fukao T; Orii T; Tomatsu S
    Mol Genet Metab; 2017 Mar; 120(3):247-254. PubMed ID: 28065440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparan sulfate proteoglycans: The sweet side of development turns sour in mucopolysaccharidoses.
    De Pasquale V; Pavone LM
    Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165539. PubMed ID: 31465828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anatomical changes and pathophysiology of the brain in mucopolysaccharidosis disorders.
    Bigger BW; Begley DJ; Virgintino D; Pshezhetsky AV
    Mol Genet Metab; 2018 Dec; 125(4):322-331. PubMed ID: 30145178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III.
    de Ruijter J; de Ru MH; Wagemans T; Ijlst L; Lund AM; Orchard PJ; Schaefer GB; Wijburg FA; van Vlies N
    Mol Genet Metab; 2012 Dec; 107(4):705-10. PubMed ID: 23084433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of Glycosaminoglycans in Urine by Isotope-Dilution Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometry.
    Zhang H; Young SP; Millington DS
    Curr Protoc; 2023 Mar; 3(3):e701. PubMed ID: 36929617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn screening and diagnosis of mucopolysaccharidoses.
    Tomatsu S; Fujii T; Fukushi M; Oguma T; Shimada T; Maeda M; Kida K; Shibata Y; Futatsumori H; Montaño AM; Mason RW; Yamaguchi S; Suzuki Y; Orii T
    Mol Genet Metab; 2013; 110(1-2):42-53. PubMed ID: 23860310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competitive binding of extracellular accumulated heparan sulfate reduces lysosomal storage defects and triggers neuronal differentiation in a model of Mucopolysaccharidosis IIIB.
    De Pasquale V; Scerra G; Scarcella M; D'Agostino M; Pavone LM
    Biochim Biophys Acta Mol Cell Res; 2021 Oct; 1868(11):119113. PubMed ID: 34329663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII.
    Rowan DJ; Tomatsu S; Grubb JH; Montaño AM; Sly WS
    J Inherit Metab Dis; 2013 Mar; 36(2):235-46. PubMed ID: 22971960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Heparan Sulfate Proteoglycans as a Novel Therapeutic Strategy for Mucopolysaccharidoses.
    De Pasquale V; Sarogni P; Pistorio V; Cerulo G; Paladino S; Pavone LM
    Mol Ther Methods Clin Dev; 2018 Sep; 10():8-16. PubMed ID: 29942826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS.
    Tanaka N; Kida S; Kinoshita M; Morimoto H; Shibasaki T; Tachibana K; Yamamoto R
    Mol Genet Metab; 2018 Sep; 125(1-2):53-58. PubMed ID: 30064964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
    Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arylsulfatase K inactivation causes mucopolysaccharidosis due to deficient glucuronate desulfation of heparan and chondroitin sulfate.
    Trabszo C; Ramms B; Chopra P; Lüllmann-Rauch R; Stroobants S; Sproß J; Jeschke A; Schinke T; Boons GJ; Esko JD; Lübke T; Dierks T
    Biochem J; 2020 Sep; 477(17):3433-3451. PubMed ID: 32856704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Unifying Hypothesis of Alzheimer's Disease: Heparan Sulfate Proteoglycans/Glycosaminoglycans Are Key as First Hypothesized Over 30 Years Ago.
    Snow AD; Cummings JA; Lake T
    Front Aging Neurosci; 2021; 13():710683. PubMed ID: 34671250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of glycosaminoglycans in urine by isotope-dilution liquid chromatography-electrospray ionization tandem mass spectrometry.
    Zhang H; Young SP; Millington DS
    Curr Protoc Hum Genet; 2013; Chapter 17():Unit 17.12. PubMed ID: 23315926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel heparan sulfate assay by using automated high-throughput mass spectrometry: Application to monitoring and screening for mucopolysaccharidoses.
    Shimada T; Kelly J; LaMarr WA; van Vlies N; Yasuda E; Mason RW; Mackenzie W; Kubaski F; Giugliani R; Chinen Y; Yamaguchi S; Suzuki Y; Orii KE; Fukao T; Orii T; Tomatsu S
    Mol Genet Metab; 2014; 113(1-2):92-9. PubMed ID: 25092413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated LysoGb3 Concentration in the Neuronopathic Forms of Mucopolysaccharidoses.
    Baydakova G; Ilyushkina A; Gaffke L; Pierzynowska K; Bychkov I; Ługowska A; Wegrzyn G; Tylki-Szymanska A; Zakharova E
    Diagnostics (Basel); 2020 Mar; 10(3):. PubMed ID: 32183018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
    Zhang H; Wood T; Young SP; Millington DS
    Mol Genet Metab; 2015 Feb; 114(2):123-8. PubMed ID: 25458519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UPLC-MS/MS detection of disaccharides derived from glycosaminoglycans as biomarkers of mucopolysaccharidoses.
    Auray-Blais C; Lavoie P; Tomatsu S; Valayannopoulos V; Mitchell JJ; Raiman J; Beaudoin M; Maranda B; Clarke JT
    Anal Chim Acta; 2016 Sep; 936():139-48. PubMed ID: 27566349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.